National Multicenter Study on the Comparison of Robotic and Open Thymectomy for Thymic Neoplasms in Myasthenic Patients: Surgical, Neurological and Oncological Outcomes
Elisa Sicolo,Carmelina Cristina Zirafa,Gaetano Romano,Jury Brandolini,Angela De Palma,Stefano Bongiolatti,Filippo Tommaso Gallina,Sara Ricciardi,Michelangelo Maestri,Melania Guida,Riccardo Morganti,Graziana Carleo,Giovanni Mugnaini,Riccardo Tajè,Fabrizia Calabró,Alessandra Lenzini,Federico Davini,Giuseppe Cardillo,Francesco Facciolo,Luca Voltolini,Giuseppe Marulli,Piergiorgio Solli,Franca Melfi
DOI: https://doi.org/10.3390/cancers16020406
2024-01-19
Cancers
Abstract:Thymectomy is the gold standard in the treatment of thymic neoplasm and plays a key role in the therapeutic path of myasthenia gravis. For years, sternotomy has been the traditional approach for removing anterior mediastinal lesions, although the robotic thymectomy is now widely performed. The literature is still lacking in papers comparing the two approaches and evaluating long-term oncological and neurological outcomes. This study aims to analyze the postoperative results of open and robotic thymectomy for thymic neoplasms in myasthenic patients. Surgical, oncological and neurological data of myasthenic patients affected by thymic neoplasms and surgically treated with extended thymectomy, both with the open and the robotic approach, in six Italian Thoracic Centers between 2011 and 2021 were evaluated. A total of 213 patients were enrolled in the study: 110 (51.6%) were treated with the open approach, and 103 (48.4%) were treated with robotic surgery. The open surgery, compared with the robotic, presented a shorter operating time (p < 0.001), a higher number of postoperative complications (p = 0.038) and longer postoperative hospitalization (p = 0.006). No other differences were observed in terms of surgical, oncological or neurological outcomes. The robotic approach can be considered safe and feasible, comparable to the open technique, in terms of surgical, oncological and neurological outcomes.
oncology